Lehman Brothers Global Healthcare Conference In Brief
This article was originally published in The Gray Sheet
Executive Summary
Gen-Probe pursues HPV assay: Human papillomavirus test technology access is being sought by the company, which has held discussions with "three or four" developers thus far about potential "ways to collaborate," CFO Herm Rosenman reported March 3 at the Lehman Brothers Global Healthcare Conference in South Beach, Florida. HPV market participants include Digene (DNAwithPap) and Roche (Amplicor). Should discussions be unsuccessful, Gen-Probe "will continue to engineer our own" intellectual property to work around current barriers to entering the market, according to Rosenman. Gen-Probe projects $235 mil.-$245 mil. in revenue this year, supported by strong sales of its Tigris automated nucleic acid test platform (1"The Gray Sheet" Jan. 5, 2004, p. 5)...
You may also be interested in...
Varian, Boston Scientific FDA Approvals Aid Q1 Double-Digit Stock Gains
Varian Medical Systems' receipt of 510(k) clearance for its On-Board Imaging tumor tracking accessory helped the radiation oncology firm's stock soar 24.9% in the first quarter - jumping $17.21 to close at $86.31
Varian, Boston Scientific FDA Approvals Aid Q1 Double-Digit Stock Gains
Varian Medical Systems' receipt of 510(k) clearance for its On-Board Imaging tumor tracking accessory helped the radiation oncology firm's stock soar 24.9% in the first quarter - jumping $17.21 to close at $86.31
AdvaMed 2004 Annual Meeting In Brief
Code of ethics roll-out: To generate adoption of its ethics code beyond member companies, AdvaMed has mailed a related brochure to 130,000 healthcare professionals, as well as a letter from President Pam Bailey to 3,000 healthcare professional societies and 2,000 hospitals, Exec VP-Strategic Planning & Implementation Blair Childs reports. Bailey also is calling 30 "major physician organizations" to discuss collaborative opportunities, Childs notes. The voluntary code, announced at last year's annual meeting, became effective Jan. 1 (1"The Gray Sheet" March 24, 2003, p. 6)...